A systemic review of published studies found that there is a notable lack of studies on the use of medical cannabis in children, and a minimal number of randomized, controlled trials, which are needed to confirm the effectiveness of this treatment. The study was published in the journal Pediatrics. Investigators from the Massachusetts General Hospital (MGH) including Shane Shucheng Wong, MD, and Timothy Wilens, MD report that their review suggests only two pediatric uses of medical cannabis – to relieve chemotherapy-induced nausea and vomiting and to reduce seizures – are supported by existing studies.
“Medical cannabis is now legal in 29 states and the District of Columbia, and in those areas with active programs, children and adolescents can legally access medical cannabis with certification from their doctor and consent from a parent or guardian,” says lead author Wong. “This means that doctors